Understanding the Evolving Pathophysiology of Coronavirus Disease 2019 and Adult Nursing Management - 26/07/24
Résumé |
Coronavirus disease 2019 (COVID-19) was first identified in December 2019 and quickly became a global pandemic. The understanding of the pathophysiology, treatment, and management of the disease has evolved since the beginning of the pandemic in 2020. COVID-19 can be complicated by immune system dysfunction, lung injury with hypoxemia, acute kidney injury, and coagulopathy. The treatment and management of COVID-19 is based on the severity of illness, ranging from asymptomatic to severe and often life-threatening disease. The 3 main recommended medication classes include antivirals, immunomodulators, and anticoagulants. Other supportive therapies include ensuring adequate oxygenation, mechanical ventilation, and prone positioning.
Le texte complet de cet article est disponible en PDF.Keywords : COVID-19, Coronavirus, SARS-CoV-2, Evidenced-based practice, Pathophysiology
Plan
Vol 36 - N° 3
P. 295-321 - septembre 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.

